Table 4.
Leucovorin and fluorouracil with or without oxaliplatin (n=3829) |
Capecitabine with or without oxaliplatin (n=1927) |
|
---|---|---|
All adverse events | 1731 (45%) | 690 (36%) |
Neutropenia | 908 (24%) | 91 (5%) |
Diarrhoea | 475 (12%) | 296 (15%) |
Neuropathy | 295 (8%) | 113 (6%) |
Vomiting or nausea | 203 (5%) | 141 (7%) |
Stomatitis, all | 135 (4%) | 6 (<1%) |
Hand–foot syndrome | 30 (<1%) | 228 (12%) |
Febrile neutropenia | 80 (2%) | 7 (<1%) |
Neutropenic fever or sepsis | 20 (<1%) | 2 (<1%) |
Data are n (%). The denominators are the numbers of patients who actually received the treatment regimens considered in this comparison.